These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3519017

  • 1. Dynamic changes in plasma inactive renin levels in Bartter's syndrome after administration of captopril and angiotensin II.
    Nagai H, Matsunaga M, Ogawa K, Pak CH, Kanatsu K, Hara A, Kono T, Kawai C.
    Clin Exp Pharmacol Physiol; 1986 Jan; 13(1):69-75. PubMed ID: 3519017
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hypotensive response to angiotensin II analogue and angiotensin I converting enzyme inhibitor in pseudo-Bartter's syndrome.
    Sasaki H, Kawasaki T, Fujisawa M, Motooka Y, Asano T, Okumura M.
    Jpn Heart J; 1981 Jul; 22(4):689-93. PubMed ID: 6272003
    [Abstract] [Full Text] [Related]

  • 4. Independent roles of prostaglandins and the renin-angiotensin system in abnormal vascular reactivity in Bartter's syndrome.
    Fujita T, Ando K, Sato Y, Yamashita K, Nomura M, Fukui T.
    Am J Med; 1982 Jul; 73(1):71-6. PubMed ID: 7046439
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of prostaglandin synthetase inhibition on captopril-induced changes in renal function in Bartter's syndrome.
    Rudin A, Granérus G, Aurell M.
    Scand J Urol Nephrol Suppl; 1984 Jul; 79():59-62. PubMed ID: 6433438
    [Abstract] [Full Text] [Related]

  • 7. [Bartter's syndrome. Effect of captopril on arterial pressure].
    Schnitzler EJ, Ferraris J, Gianantonio CA.
    Bol Med Hosp Infant Mex; 1983 Apr; 40(4):192-7. PubMed ID: 6347220
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
    Klaus D, Witzgall H, Zehner J, Dürr H, Lange H.
    Dtsch Med Wochenschr; 1976 Sep 10; 101(37):1357-9. PubMed ID: 954592
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT, Aurecchia SA, Sindler BH, Melby JC.
    J Clin Pharmacol; 1982 Sep 10; 22(11-12):505-12. PubMed ID: 6761369
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of captopril-induced renin release by angiotensin II.
    Mersey JH, Ceballos L, Swartz S.
    J Cardiovasc Pharmacol; 1987 Nov 10; 10(5):575-9. PubMed ID: 2447408
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of angiotensin I converting enzyme inhibition and calcium channel blockade on plasma levels of active and inactive renin in conscious rabbits.
    Eisen V, Munday MR, Slater JD.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2331-5. PubMed ID: 2440439
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.